AADI BIOSCIENCE INC's ticker is and the CUSIP is 00032Q104. A total of 77 filers reported holding AADI BIOSCIENCE INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $683,157 | -22.2% | 141,148 | +10.0% | 0.00% | – |
| Q2 2023 | $877,729 | +0.7% | 128,323 | +6.6% | 0.00% | – |
| Q1 2023 | $871,196 | -44.6% | 120,331 | -1.8% | 0.00% | – |
| Q4 2022 | $1,571,739 | -12.0% | 122,505 | -3.1% | 0.00% | – |
| Q3 2022 | $1,786,000 | +8.0% | 126,366 | -5.9% | 0.00% | – |
| Q2 2022 | $1,654,000 | +168.9% | 134,224 | +270.2% | 0.00% | – |
| Q1 2022 | $615,000 | -30.8% | 36,258 | -1.5% | 0.00% | – |
| Q4 2021 | $889,000 | – | 36,808 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 26,666 | $129,063 | 17.55% |
| Alerce Investment Management, L.P. | 1,630,830 | $7,893,217 | 13.49% |
| ACUTA CAPITAL PARTNERS, LLC | 1,849,402 | $8,951,106 | 6.00% |
| Decheng Capital Management III (Cayman), LLC | 526,329 | $2,547,432 | 0.85% |
| Vivo Capital, LLC | 509,572 | $6,456,277 | 0.71% |
| Knott David M Jr | 265,000 | $1,283 | 0.49% |
| Ghost Tree Capital, LLC | 250,000 | $1,210,000 | 0.40% |
| Avoro Capital Advisors LLC | 2,849,402 | $13,791,106 | 0.22% |
| Lion Point Capital, LP | 82,423 | $398,927 | 0.18% |
| Soleus Capital Management, L.P. | 333,227 | $1,612,819 | 0.15% |